Evidence map›Paper›PMID 24145534›Full record

ArticleAntimicrobial agents and chemotherapy2014

First Report of bla(IMP-8) in Raoultella planticola.

Sung-Pin Tseng, Jann-Tay Wang, Chih-Yuan Liang, Pei-Shan Lee, Yee-Chun Chen, Po-Liang Lu

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Clinical case reports · 2025
    Article
  3. Article
  4. Article
  5. Genomic Characterization of a Carbapenem-ResistantInfection and drug resistance · 2024
    Article
  6. Article
  7. Rare Case ofDiseases (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. A rare case ofClinical case reports · 2020
    Article
  12. Article
  13. Comprehensive Genome Analysis of Carbapenem-ResistantAntimicrobial agents and chemotherapy · 2019
    Article
  14. Review
  15. Article
  16. A novel case ofBMJ case reports · 2017
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Sung-Pin TsengDepartment of Medical Laboratory Science and Biotechnology, Kaohsiung Medical University, Kaohsiung, Taiwan.
Jann-Tay Wang
Chih-Yuan Liang
Pei-Shan Lee
Yee-Chun Chen
Po-Liang Lu
Kaohsiung Medical University · TWKaohsiung Medical University Chung-Ho Memorial Hospital · TWNational Taiwan University Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two carbapenem-resistant Raoultella planticola clinical isolates were isolated from patients with pneumonia and Port-A catheter-related bacteremia, respectively, in Taiwan. These isolates remained susceptible to fluoroquinolone, aminoglycoside, and colistin. Though the two isolates had the same antibiogram, plasmidic carbapenemase blaIMP-8, class 1 integron cassette (dfrA12-orfF-aadA2), and qnrB2, they had different pulsed-field gel electrophoresis patterns, plasmid sizes, and outer membrane protein loss profiles. To our knowledge, this is the first report of blaIMP-8 found in R. planticola. Interestingly, blaIMP-8 is the most common carbapenemase found in Klebsiella pneumoniae in Taiwan. In the literature, carbapenemase genes in R. planticola in each country were also found in carbapenem-resistant Enterobacteriaceae in the same country.

Indexed as

Agedbeta-LactamasesElectrophoresis, Gel, Pulsed-FieldFemaleHumansKlebsiella pneumoniaeMaleMiddle AgedPeptostreptococcusbeta-LactamasesIMP-8 enzyme

Identifiers

PMID24145534
PMCPMC3910719
OpenAlexW2042193425

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.